Krystal Biotech (KRYS) Interest & Investment Income (2021 - 2025)
Historic Interest & Investment Income for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $6.6 million.
- Krystal Biotech's Interest & Investment Income fell 964.78% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year decrease of 381.8%. This contributed to the annual value of $29.7 million for FY2024, which is 3110.41% up from last year.
- Latest data reveals that Krystal Biotech reported Interest & Investment Income of $6.6 million as of Q3 2025, which was down 964.78% from $7.5 million recorded in Q2 2025.
- Krystal Biotech's Interest & Investment Income's 5-year high stood at $7.6 million during Q1 2024, with a 5-year trough of $30000.0 in Q2 2021.
- Its 5-year average for Interest & Investment Income is $4.2 million, with a median of $4.8 million in 2023.
- Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 378428.57% in 2022, then plummeted by 964.78% in 2025.
- Krystal Biotech's Interest & Investment Income (Quarter) stood at $70000.0 in 2021, then surged by 3784.29% to $2.7 million in 2022, then soared by 176.54% to $7.5 million in 2023, then dropped by 3.07% to $7.3 million in 2024, then decreased by 9.54% to $6.6 million in 2025.
- Its Interest & Investment Income was $6.6 million in Q3 2025, compared to $7.5 million in Q2 2025 and $7.4 million in Q1 2025.